Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1992-05-27
1994-08-16
Hill, Jr., Robert J.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
530399, 530350, C07K 1300, A61K 3736
Patent
active
053388402
ABSTRACT:
Glioma-derived growth factor is purified from the culture media used to maintain mammalian glioma cells. The protein stimulates mitogenesis of mammalian vascular endothelial cells and is useful for the promotion of vascular development and repair. This unique growth factor is also useful in the promotion of tissue repair.
REFERENCES:
patent: 4456550 (1984-06-01), Dvorak et al.
patent: 4665037 (1987-05-01), Stolowitz
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5219739 (1993-06-01), Tischer et al.
Stryer 1981 Biochemistry, W.H. Freenam & Co. San Francisco, p. 629.
Hammacher et al. 1988 Eur. J. Biochem. 176:179.
Nister et al. 1988. Cell. 52:791-799.
Libermann et al. 1987 EMBO J. 6(6):1627.
G. L. Conn, Endothelial Cell Growth Factors, Yeshiva University, New York, N.Y. (1987).
Bayne Marvin L.
Conn Gregory L.
Thomas, Jr. Kenneth A.
Carlson K. Cochrane
Hill Jr. Robert J.
Matukaitis Paul D.
Merck & Co. , Inc.
Tribble Jack L.
LandOfFree
DNA encoding glioma-derived growth factor having vascular endoth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA encoding glioma-derived growth factor having vascular endoth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA encoding glioma-derived growth factor having vascular endoth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-952991